Taiyo is using Fi 2013 to promote its SunAmla fruit extract as a wellness ingredient for dietary supplements.
The company is keen to communicate to visitors the findings of new clinical research supporting the role of the Indian gooseberry extract in the prevention of cardiovascular disorders. The in vitro study published in the British Journal of Nutrition was the first time researchers had evaluated the potential use of the fruit extract in cardiovascular health, and provides a scientific basis for the traditional use of amla fruit for its anti-inflammatory and anti-coagulant activity.
“Amla fruits contain a unique combination of vitamin C, gallic acid and ellagic acid in a specific complex form,” said Dr Lekh R Juneja, executive vice president of Taiyo Kagaku Japan, parent company of Taiyo. “The fruits have been used for thousands of years in traditional Ayurveda treatments to improve health and beauty.”
Due to the fruit’s history of use and natural active components, Taiyo says it is ideal for anti-ageing, antioxidant, beauty and blood circulation dietary supplement concepts. To this end, Taiyo’s SunAmla is a water-soluble powder produced by mild water extraction from the fruit.
As yet Taiyo doesn’t have any European customers for SunAmla but Dr Juneja says it is being used in a shot drink and other dietary supplement products that are on sale in the USA and Japan.
Taiyo is working towards obtaining EFSA-approved claims for the extract through human trials.
